M.D. Sass LLC Purchases Shares of 41,926 Danaher Corporation $DHR

M.D. Sass LLC bought a new position in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 41,926 shares of the conglomerate’s stock, valued at approximately $7,986,000. Danaher comprises about 0.5% of M.D. Sass LLC’s investment portfolio, making the stock its 27th biggest position.

Other hedge funds have also added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. lifted its position in Danaher by 303.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after buying an additional 186,584 shares during the period. Legal & General Group Plc boosted its holdings in Danaher by 1.0% in the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after acquiring an additional 43,169 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Danaher by 51.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 271,734 shares of the conglomerate’s stock worth $62,205,000 after purchasing an additional 92,323 shares during the last quarter. Advisors Capital Management LLC boosted its stake in Danaher by 14.0% in the 4th quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock worth $12,555,000 after purchasing an additional 6,720 shares in the last quarter. Finally, Handelsbanken Fonder AB grew its position in Danaher by 10.9% during the 2nd quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock valued at $55,091,000 after purchasing an additional 28,425 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Down 1.5%

Shares of NYSE DHR opened at $199.62 on Wednesday. The stock has a market capitalization of $140.33 billion, a P/E ratio of 35.46, a PEG ratio of 2.52 and a beta of 0.78. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The business’s 50 day moving average is $193.74 and its two-hundred day moving average is $192.50. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.77 EPS. As a group, research analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have commented on DHR. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. JPMorgan Chase & Co. dropped their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Jefferies Financial Group reiterated a “buy” rating and issued a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. TD Cowen cut their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Finally, Piper Sandler assumed coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price for the company. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.